Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
Funding for multicenter, international phase 2/3 clinical trials on medicinal products for rare cancer treatment (including drug repurposing). |
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00. Carol Barnwell: cbarnwell@researchmar.net Ext.: 1670 Marta López: mlopez4@researchmar.net Ext.: 1576 |
Convocatòria (URL)
https://www.fondation-arc.org/attract |
Informació addicional
The submission of proposals follows a two-stage procedure: |
Requisits
Please see the guidelines to check the complete list of requirements. |
Dotació
FCAECC does not have a maximum funding per grant; the amount depends on the scientific and medical needs and should be justified in the requested budget. However, it is highly recommended to respect the available budget (€ 1M) and anticipated number of fundable research groups. |
Durada
3 years |
AVÍS IMPORTANT
The call is made at European level but each partner of the consortium is funded by its national funding agency and must follow its national funding rules. Spanish participants are funded by FCAECC. There are eligibility requirements for the institutions and principal investigators funded by FCAECC. (please see the Call text). Due to the complexity of the call, if you are interested in submitting an application we strongly recommend that you contact the Research Grants and Contracts Office well in advance of the deadline. |
Arxius
Arxiu |
---|
ATTRACT2025_CallText.pdf |